首页> 美国卫生研究院文献>Oxidative Medicine and Cellular Longevity >Resveratrol Prevents ROS-Induced Apoptosis in High Glucose-Treated Retinal Capillary Endothelial Cells via the Activation of AMPK/Sirt1/PGC-1α Pathway
【2h】

Resveratrol Prevents ROS-Induced Apoptosis in High Glucose-Treated Retinal Capillary Endothelial Cells via the Activation of AMPK/Sirt1/PGC-1α Pathway

机译:白藜芦醇通过激活AMPK / Sirt1 /PGC-1α途径防止ROS诱导的高糖处理视网膜毛细血管内皮细胞凋亡。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Resveratrol (RSV) is used as a protective therapy against diabetic retinopathy. However, the mechanism(s) underlying this protective effect has not been fully elucidated. Bovine retinal capillary endothelial cells (BRECs), an in vitro model, were used to investigate the mechanism of RSV. Our results showed that high glucose induced significant cellular apoptosis in BRECs, which was accompanied by increased intracellular levels of reactive oxygen species (ROS) and cleaved caspase-3. The glucose-induced apoptosis and ROS elevation were both inhibited by RSV. High glucose was found to decrease the levels of phosphorylated AMP-activated protein kinase (p-AMPK), which was accompanied by increased levels of Sirt1 and PGC-1α. These changes were reversed by RSV. We also demonstrated that AMPK regulates the modulations of Sirt1 and PGC-1α using specific inhibitors of AMPK and Sirt1 and small interfering RNAs of PGC-1α. In summary, the current study demonstrates that RSV is effective against high glucose-induced cellular apoptosis and its action is exerted via the inhibition of ROS/AMPK/Sirt1/PGC-1α pathway.
机译:白藜芦醇(RSV)被用作针对糖尿病性视网膜病的保护性疗法。但是,尚未完全阐明保护作用的潜在机制。牛视网膜毛细血管内皮细胞(BRECs),一种体外模型,用于研究RSV的机制。我们的结果表明,高糖诱导BRECs发生明显的细胞凋亡,并伴随着细胞内活性氧(ROS)水平的增加和caspase-3的裂解。葡萄糖诱导的细胞凋亡和ROS升高均被RSV抑制。发现高葡萄糖可降低磷酸化的AMP活化蛋白激酶(p-AMPK)的水平,并伴随增加Sirt1和PGC-1α的水平。这些更改已被RSV撤消。我们还证明了AMPK使用AMPK和Sirt1的特异性抑制剂以及PGC-1α的小干扰RNA来调节Sirt1和PGC-1α的调节。总而言之,当前的研究表明,RSV对高糖诱导的细胞凋亡有效,其作用是通过抑制ROS / AMPK / Sirt1 /PGC-1α途径发挥的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号